Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD
2023-09-25 09:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
2023-09-25 07:41
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
2023-09-22 22:03
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
2023-09-21 22:00
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
2023-09-21 18:05
Latest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.
2023-09-21 15:00
Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023
2023-09-21 14:06
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB
2023-09-21 08:00
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets
2023-09-21 07:05
Diana Bracco: "Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses"
2023-09-21 01:47
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
2023-09-20 23:27
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
2023-09-20 20:00
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
2023-09-20 09:00
Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis
2023-09-20 08:26
Hospital Clinica Biblica Joins Global Provider Network to Transform Healthcare in Costa Rica
2023-09-20 03:58
New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda
2023-09-20 00:00
Verista Awarded by Frost & Sullivan for Providing Next-Generation Compliance and Quality Management Solutions in the Life Sciences Industry
2023-09-19 21:00
Cerecin strengthens position in neurometabolism with addition to pipeline
2023-09-19 19:39
Clarivate Unveils Citation Laureates 2023 - Annual List of Researchers of Nobel Class
2023-09-19 15:00
Neusoft Holds the Top Market Share of Medical Imaging Information System in China
2023-09-19 14:25
1
83
84
85
86
87
531